Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.43T
1-Year Est. Return 25.4%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Quarter Est. Return
1 Year Est. Return
+25.4%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.27T
AUM Growth
-$18.6B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,591
New
Increased
Reduced
Closed

Top Buys

1
+$2.75B
2
+$2.14B
3
+$1.64B
4
AMZN icon
Amazon
AMZN
+$1.53B
5
META icon
Meta Platforms (Facebook)
META
+$983M

Top Sells

1
+$187M
2
+$152M
3
+$141M
4
MRK icon
Merck
MRK
+$137M
5
TDG icon
TransDigm Group
TDG
+$133M

Sector Composition

1 Technology 29.39%
2 Financials 14.52%
3 Healthcare 11.04%
4 Consumer Discretionary 10.43%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMAA
3576
Drugs Made In America Acquisition Corp
DMAA
$345M
$456K ﹤0.01%
+45,462
FBYD icon
3577
Falcon's Beyond
FBYD
$468M
$454K ﹤0.01%
52,065
+981
LUCD icon
3578
Lucid Diagnostics
LUCD
$121M
$452K ﹤0.01%
303,175
+23,671
WLYB icon
3579
John Wiley & Sons Class B
WLYB
$1.95B
$451K ﹤0.01%
10,108
+1,126
RGS icon
3580
Regis Corp
RGS
$73.9M
$451K ﹤0.01%
24,844
+2,074
VRCA icon
3581
Verrica Pharmaceuticals
VRCA
$38.8M
$450K ﹤0.01%
101,849
+54,122
GBIO icon
3582
Generation Bio
GBIO
$43.6M
$449K ﹤0.01%
110,842
-2,866
SVM
3583
Silvercorp Metals
SVM
$1.5B
$449K ﹤0.01%
116,421
+11,522
BHM icon
3584
Bluerock Homes Trust
BHM
$44.4M
$448K ﹤0.01%
39,384
+1,528
AARD
3585
Aardvark Therapeutics
AARD
$322M
$448K ﹤0.01%
+59,600
CTM icon
3586
Castellum
CTM
$97.7M
$444K ﹤0.01%
418,525
+118,882
MODD icon
3587
Modular Medical
MODD
$32M
$443K ﹤0.01%
406,127
+85,009
FSEA icon
3588
First Seacoast Bancorp
FSEA
$54.3M
$441K ﹤0.01%
37,828
+1,974
TOI icon
3589
The Oncology Institute
TOI
$373M
$440K ﹤0.01%
385,747
+38,400
BAER icon
3590
Bridger Aerospace
BAER
$96.1M
$440K ﹤0.01%
388,901
+19,284
OCS icon
3591
Oculis Holding
OCS
$1.13B
$439K ﹤0.01%
23,052
+6,308
SKE
3592
Skeena Resources
SKE
$2.33B
$438K ﹤0.01%
43,483
+4,134
GSIT icon
3593
GSI Technology
GSIT
$135M
$438K ﹤0.01%
215,736
+7,013
RFIL icon
3594
RF Industries
RFIL
$90.6M
$436K ﹤0.01%
92,891
+8,271
RNTX
3595
Rein Therapeutics
RNTX
$32.2M
$436K ﹤0.01%
246,096
+4,659
OM icon
3596
Outset Medical
OM
$238M
$436K ﹤0.01%
39,356
+1,772
VIGL
3597
DELISTED
Vigil Neuroscience
VIGL
$435K ﹤0.01%
244,534
+16,010
INUV icon
3598
Inuvo
INUV
$49M
$435K ﹤0.01%
122,568
+2,179
VNRX icon
3599
VolitionRX
VNRX
$49.6M
$434K ﹤0.01%
761,951
+18,108
VALE icon
3600
Vale
VALE
$46.8B
$434K ﹤0.01%
43,522
-2,239
142 143
144
145 146